Nachrichten zur Taro Pharmaceuticals Industries Ltd. Aktie

Taro Pharmaceutical EPS beats by $0.25, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taro Pharmaceutical (TARO) Q1 Earnings and Revenues Beat Estimates

Taro (TARO) delivered earnings and revenue surprises of 29.76% and 7.23%, respectively, for the quarter ended June 2021. Do the…

Taro Pharma (TARO) Sees Hammer Chart Pattern: Time to Buy?

Taro Pharmaceutical Industries (TARO) has been struggling lately, but the selling pressure may be coming to an end soon....…

TARO PHARMACEUTICAL INDUSTRIES LTD: 20-F Report

20-F...…

Taro Pharmaceutical EPS misses by $0.11, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Preview for Taro Pharmaceutical Indus

Taro Pharmaceutical Indus (NYSE:TARO) unveils its next round of earnings this Wednesday, May 19. Here is Benzingas everything-that-matters guide for…

Taro Pharmaceutical EPS misses by $0.15, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taro Pharmaceutical (TARO) Q2 Earnings and Revenues Top Estimates

Taro (TARO) delivered earnings and revenue surprises of 53.25% and 14.00%, respectively, for the quarter ended September 2020. Do the…

Taro Pharmaceutical EPS beats by $0.41, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taro Pharmaceutical launches generic Deferiprone in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sun Pharma Q1 Results: Taro Troubles In U.S. Cause Over Rs 1,600 Crore Loss

Sun Pharma provided a sum of Rs 3,176 crore to settle Taro Pharmas generic drug price-fixing allegations in the U.S....…

Taro Pharmaceutical (TARO) Misses Q1 Earnings and Revenue Estimates

Taro (TARO) delivered earnings and revenue surprises of -34.48% and -25.71%, respectively, for the quarter ended June 2020. Do the…

Taro Pharma to Pay More Than $200 Million to Settle Generic-Drug Price-Fixing Case

The company reached a deferred-prosecution agreement in which it is cooperating with the federal governments yearslong investigation, and agreed to…

TARO PHARMACEUTICAL INDUSTRIES LTD: 20-F Report

20-F...…

NTC gewährt in Israel Lizenzen und Vertriebsrechte an Taro Pharmaceutical Industries für seine feste Kombination eines ophthalmischen Quinolon-Antibiotikums mit einem entzündungshemmenden Steroid

NTC Srl: Mailand (ots/PRNewswire) - NTC Srl, ein F&E-orientiertes Pharmaunternehmen mit Sitz in Italien, hat Taro Pharmaceutical Industries ("Taro"), einem…

Taro Pharmaceutical (TARO) Misses Q4 Earnings Estimates

Taro (TARO) delivered earnings and revenue surprises of -7.19% and 3.98%, respectively, for the quarter ended March 2020. Do the…

Taro Pharmaceutical EPS misses by $0.11, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

New finance chief at Taro Pharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taro Pharma Recalls Certain Lots Of Phenytoin Oral Suspension

Taro Pharmaceuticals U.S.A., Inc., the U.S.-based business of Israeli Pharma firm Taro Pharmaceutical Industries, Ltd., recalled certain lots of seizure…

Former Taro Pharmaceutical VP Of Sales And Marketing Indicted for Price Fixing

Taro Pharmaceutical Industries Ltd (NYSE: TARO) former Vice President of Sales and Marketing Ara Aprahamian has been indicted by the Justice…

Former executive of Taro Pharmaceutical indicted in U.S. for price-fixing

A former sales and marketing executive of Taro Pharmaceutical Industries Ltd, Ara Aprahamian, has been indicted for price-fixing and bid-rigging, among other charges....…

Taro Pharmaceutical (TARO) Surpasses Q3 Earnings Estimates

Taro (TARO) delivered earnings and revenue surprises of 14.29% and -14.14%, respectively, for the quarter ended December 2019. Do the…

Taro Pharmaceutical EPS beats by $0.22, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Taro Pharma Recalls Certain Lot Of Lamotrigine Tablets

Taro Pharmaceuticals U.S.A., Inc., the U.S.-based business of Israeli Pharma firm Taro Pharmaceutical Industries, Ltd., recalled a certain lot of…